• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

: 成骨细胞中变异的功能分析及基因组调控的遗传学和基因组学。

Genetics and Genomics of : Functional Analysis of Variants and Genomic Regulation in Osteoblasts.

机构信息

Department of Genetics, Microbiology and Statistics, Faculty of Biology, CIBERER, IBUB, IRSJD, Universitat de Barcelona, 08028 Barcelona, Spain.

Musculoskeletal Research Group, Centro de Investigación Biomédica en Red en Fragilidad y Envejecimiento Saludable (CIBERFES), ISCIII, IMIM (Hospital del Mar Medical Research Institute), 08003 Barcelona, Spain.

出版信息

Int J Mol Sci. 2021 Jan 6;22(2):489. doi: 10.3390/ijms22020489.

DOI:10.3390/ijms22020489
PMID:33419004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7825314/
Abstract

encodes the sclerostin protein, which acts as a key extracellular inhibitor of the canonical Wnt pathway in bone, playing a crucial role in skeletal development and bone homeostasis. The objective of this work was to assess the functionality of two variants previously identified (the rare variant rs570754792 and the missense variant p.Val10Ile) and to investigate the physical interactors of the proximal promoter region in bone cells. Through a promoter luciferase reporter assay we show that the minor allele of rs570754792, a variant located in the extended TATA box motif, displays a significant decrease in promoter activity. Likewise, through western blot studies of extracellular and intracellular sclerostin, we observe a reduced expression of the p.Val10Ile mutant protein. Finally, using a circular chromosome conformation capture assay (4C-seq) in 3 bone cell types (MSC, hFOB, Saos-2), we have detected physical interactions between the proximal promoter and the enhancer, several additional enhancers located between and and a distant region containing exon 18 of . In conclusion, presents functional regulatory and missense variants that affect its expression and displays physical contacts with far reaching genomic sequences, which may play a role in its regulation within bone cells.

摘要

编码骨硬化蛋白(sclerostin),该蛋白是骨中经典 Wnt 通路的关键细胞外抑制剂,在骨骼发育和骨稳态中发挥着重要作用。本研究旨在评估先前鉴定的两种变体(罕见变体 rs570754792 和错义变体 p.Val10Ile)的功能,并研究骨细胞中近端启动子区域的物理相互作用体。通过启动子荧光素酶报告基因检测,我们发现位于扩展 TATA 盒基序中的 rs570754792 等位基因的次要等位基因,其启动子活性显著降低。同样,通过对外源和胞内骨硬化蛋白的 Western blot 研究,我们观察到 p.Val10Ile 突变蛋白的表达减少。最后,我们在 3 种骨细胞类型(MSC、hFOB、Saos-2)中使用环状染色体构象捕获分析(4C-seq),检测到近端启动子与增强子之间的物理相互作用,以及位于 和 之间的几个额外增强子,以及包含外显子 18 的远端区域。总之, 表现出功能性调节和错义变体,影响其表达,并与远距离基因组序列发生物理接触,这可能在骨细胞中发挥其调控作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7825314/1ba3c4b295fa/ijms-22-00489-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7825314/17cc5c67f03e/ijms-22-00489-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7825314/0c38667ba171/ijms-22-00489-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7825314/1ba3c4b295fa/ijms-22-00489-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7825314/17cc5c67f03e/ijms-22-00489-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7825314/0c38667ba171/ijms-22-00489-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0741/7825314/1ba3c4b295fa/ijms-22-00489-g003.jpg

相似文献

1
Genetics and Genomics of : Functional Analysis of Variants and Genomic Regulation in Osteoblasts.: 成骨细胞中变异的功能分析及基因组调控的遗传学和基因组学。
Int J Mol Sci. 2021 Jan 6;22(2):489. doi: 10.3390/ijms22020489.
2
Computational and functional characterization of four SNPs in the SOST locus associated with osteoporosis.骨质疏松症相关 SOST 基因座四个 SNP 的计算和功能特征分析。
Bone. 2018 Mar;108:132-144. doi: 10.1016/j.bone.2018.01.001. Epub 2018 Jan 4.
3
TGF-β regulates sclerostin expression via the ECR5 enhancer.TGF-β 通过 ECR5 增强子调节骨硬化蛋白的表达。
Bone. 2012 Mar;50(3):663-9. doi: 10.1016/j.bone.2011.11.016. Epub 2011 Dec 2.
4
Sost, independent of the non-coding enhancer ECR5, is required for bone mechanoadaptation.独立于非编码增强子ECR5之外的Sost,是骨骼机械适应性所必需的。
Bone. 2016 Nov;92:180-188. doi: 10.1016/j.bone.2016.09.001. Epub 2016 Sep 4.
5
Mef2c regulates bone mass through Sost-dependent and -independent mechanisms.Mef2c 通过依赖和不依赖 Sost 的机制来调节骨量。
Bone. 2024 Feb;179:116976. doi: 10.1016/j.bone.2023.116976. Epub 2023 Nov 30.
6
Control of the SOST bone enhancer by PTH using MEF2 transcription factors.甲状旁腺激素通过MEF2转录因子对SOST骨增强子的调控。
J Bone Miner Res. 2007 Dec;22(12):1957-67. doi: 10.1359/jbmr.070804.
7
Analysis of SOST expression using large minigenes reveals the MEF2C binding site in the evolutionarily conserved region (ECR5) enhancer mediates forskolin, but not 1,25-dihydroxyvitamin D or TGFβ responsiveness.使用大型微型基因对SOST表达进行分析发现,进化保守区域(ECR5)增强子中的MEF2C结合位点介导了福斯高林的反应,但不介导1,25 - 二羟基维生素D或转化生长因子β的反应。
J Steroid Biochem Mol Biol. 2016 Nov;164:277-280. doi: 10.1016/j.jsbmb.2015.09.005. Epub 2015 Sep 7.
8
DNA methylation contributes to the regulation of sclerostin expression in human osteocytes.DNA 甲基化有助于调节人破骨细胞中骨硬化蛋白的表达。
J Bone Miner Res. 2012 Apr;27(4):926-37. doi: 10.1002/jbmr.1491.
9
microRNA-96 promotes osteoblast differentiation and bone formation in ankylosing spondylitis mice through activating the Wnt signaling pathway by binding to SOST.微小 RNA-96 通过与 SOST 结合激活 Wnt 信号通路促进强直性脊柱炎小鼠成骨细胞分化和骨形成。
J Cell Biochem. 2019 Sep;120(9):15429-15442. doi: 10.1002/jcb.28810. Epub 2019 May 20.
10
Cbfa1/RUNX2 directs specific expression of the sclerosteosis gene (SOST).Cbfa1/RUNX2指导骨硬化症基因(SOST)的特异性表达。
J Biol Chem. 2004 Apr 2;279(14):13849-58. doi: 10.1074/jbc.M306249200. Epub 2004 Jan 22.

引用本文的文献

1
Genome wide detection of CNV and their association with body size in Danzhou chickens.儋州鸡全基因组拷贝数变异(CNV)检测及其与体型的关联
Poult Sci. 2024 Dec;103(12):104266. doi: 10.1016/j.psj.2024.104266. Epub 2024 Aug 25.
2
Examining craniofacial variation among crispant and mutant zebrafish models of human skeletal diseases.检查crispant 和突变斑马鱼人类骨骼疾病模型的颅面变异。
J Anat. 2023 Jul;243(1):66-77. doi: 10.1111/joa.13847. Epub 2023 Mar 1.
3
Sclerostin: From Molecule to Clinical Biomarker.骨硬化蛋白:从分子到临床生物标志物。

本文引用的文献

1
SignalP 5.0 improves signal peptide predictions using deep neural networks.SignalP 5.0 使用深度神经网络改进了信号肽预测。
Nat Biotechnol. 2019 Apr;37(4):420-423. doi: 10.1038/s41587-019-0036-z. Epub 2019 Feb 18.
2
Sclerosteosis: Report of type 1 or 2 in three Indian Tamil families and literature review.石骨症:三例印度泰米尔家庭 1 型或 2 型病例报告及文献复习。
Bone. 2018 Nov;116:321-332. doi: 10.1016/j.bone.2018.07.022. Epub 2018 Aug 2.
3
Common and rare variants of WNT16, DKK1 and SOST and their relationship with bone mineral density.
Int J Mol Sci. 2022 Apr 26;23(9):4751. doi: 10.3390/ijms23094751.
4
Wnt Pathway Extracellular Components and Their Essential Roles in Bone Homeostasis.Wnt 通路细胞外成分及其在骨稳态中的重要作用。
Genes (Basel). 2022 Jan 13;13(1):138. doi: 10.3390/genes13010138.
5
Bone Sclerostin and Dickkopf-related protein-1 are positively correlated with bone mineral density, bone microarchitecture, and bone strength in postmenopausal osteoporosis.绝经后骨质疏松症患者的骨硬化蛋白和 Dickkopf 相关蛋白-1 与骨密度、骨微结构和骨强度呈正相关。
BMC Musculoskelet Disord. 2021 May 25;22(1):480. doi: 10.1186/s12891-021-04365-8.
WNT16、DKK1 和 SOST 的常见和罕见变异体及其与骨密度的关系。
Sci Rep. 2018 Jul 19;8(1):10951. doi: 10.1038/s41598-018-29242-8.
4
4Cin: A computational pipeline for 3D genome modeling and virtual Hi-C analyses from 4C data.4Cin:一个从 4C 数据进行 3D 基因组建模和虚拟 Hi-C 分析的计算流程。
PLoS Comput Biol. 2018 Mar 9;14(3):e1006030. doi: 10.1371/journal.pcbi.1006030. eCollection 2018 Mar.
5
Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models.SOST/骨硬化蛋白基因在硬骨生成症和范可尼贫血疾病动物模型中的作用。
Metabolism. 2018 Mar;80:38-47. doi: 10.1016/j.metabol.2017.10.005. Epub 2017 Oct 25.
6
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial.罗莫佐单抗(硬骨素单克隆抗体)与特立帕肽在口服双膦酸盐治疗后绝经后骨质疏松症女性中的比较:一项随机、开放标签、3 期临床试验。
Lancet. 2017 Sep 30;390(10102):1585-1594. doi: 10.1016/S0140-6736(17)31613-6. Epub 2017 Jul 26.
7
GeneHancer: genome-wide integration of enhancers and target genes in GeneCards.基因增强子:基因卡片中增强子与靶基因的全基因组整合
Database (Oxford). 2017 Jan 1;2017. doi: 10.1093/database/bax028.
8
BPS804 Anti-Sclerostin Antibody in Adults With Moderate Osteogenesis Imperfecta: Results of a Randomized Phase 2a Trial.BPS804治疗中度成骨不全成人患者的抗硬化蛋白抗体:一项2a期随机试验的结果
J Bone Miner Res. 2017 Jul;32(7):1496-1504. doi: 10.1002/jbmr.3143. Epub 2017 Apr 19.
9
Sclerostin expression and functions beyond the osteocyte.骨硬化蛋白在骨细胞之外的表达及功能
Bone. 2017 Mar;96:45-50. doi: 10.1016/j.bone.2016.11.024. Epub 2016 Nov 23.
10
REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants.REVEL:一种预测罕见错义变异致病性的集成方法。
Am J Hum Genet. 2016 Oct 6;99(4):877-885. doi: 10.1016/j.ajhg.2016.08.016. Epub 2016 Sep 22.